Equities

Supermax Corporation Bhd

Supermax Corporation Bhd

Actions
Health CareMedical Equipment and Services
  • Price (MYR)0.93
  • Today's Change0.005 / 0.54%
  • Shares traded8.00m
  • 1 Year change+13.41%
  • Beta--
Data delayed at least 15 minutes, as of Jul 18 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Supermax Corporation Berhad is an investment holding company, engaged in the production of rubber gloves. It is an international manufacturer, distributor and marketer of medical devices, namely medical gloves and contact lenses. It operates through four segments: Investment holding, Manufacturing of gloves, Trading of gloves and Others. It manufactures various types of nitrile latex and natural rubber gloves, which are exported to over 165 countries around the world, such as the United States of America, European Union, Middle East, Asia, and South Pacific countries. The Company owns a range of brands, such as Supermax, Aurelia and Maxter, which are used by laboratories, hospitals, pharmacists, doctors, and surgeons throughout the world. It distributes its gloves through distribution centers set up around the world as well as in collaboration with a wide network of over 1,200 distributors globally. Its subsidiaries include Supermax Property Holdings Sdn Bhd and Supergamma Sdn. Bhd.

  • Revenue in MYR (TTM)689.13m
  • Net income in MYR-45.69m
  • Incorporated1997
  • Employees1.58k
  • Location
    Supermax Corporation BhdLot 38,Putra Industrial ParkBukit Rahaman PutraSUNGAI BULOH 40160MalaysiaMYS
  • Phone+60 361452328
  • Fax+60 361562191
  • Websitehttp://www.supermax.com.my/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Paragon Care Ltd.996.13m32.35m2.34bn0.0029.471.2033.752.350.01530.01240.46980.37590.68063.008.84--2.54-1.783.32-2.3340.9239.553.73-2.580.71213.040.374--29.5521.27111.05-1.5426.29-17.29
Tokai Corp (Gifu)4.13bn173.49m2.40bn4.25k13.510.9117.630.5815165.03165.033,926.202,447.901.2219.076.9232,492,240.005.195.506.587.1124.3424.764.244.542.37--0.026427.316.173.51-4.852.9432.2914.09
Getein Biotech Inc839.04m156.87m2.44bn2.14k15.571.44--2.910.48160.48162.585.220.35021.612.77611,337.706.6313.259.2418.4566.1365.5718.9228.131.97--0.185729.88-24.8514.81-43.922.3118.446.00
Visco Vision Inc384.91m62.00m2.46bn--39.725.7420.626.396.866.8642.6047.460.53972.855.99--8.5611.6811.1715.8039.4040.5615.8617.721.1621.320.270743.00-13.6825.82-51.158.740.8293--
Hangzhou Ags Medtech Co Ltd340.30m151.44m2.51bn592.0016.621.74--7.382.912.916.5427.800.37753.3613.43895,039.9016.80--17.73--70.24--44.50--24.45--0.0054--37.09--49.87------
Supermax Corporation Bhd689.13m-45.69m2.52bn1.58k--0.5207--3.65-0.0178-0.01780.2671.780.1354--11.50437,541.00-1.4423.63-1.5732.97--61.93-10.6336.075.63-4.890.019323.13-69.44-8.84-119.59--59.6313.42
Microport NeuroTech Ltd-59.73bn-59.73bn2.52bn571.00------------------------------------------------21.61--768.73------
Hangzhou Alltest Biotech Co Ltd461.44m118.71m2.54bn1.09k21.401.01--5.502.332.339.0249.430.1652.136.17657,349.004.2423.354.5726.8346.8358.3425.6939.0710.16--0.005629.79-77.7332.59-84.7526.1972.77--
SWS Hemodialysis Care Co Ltd423.34m99.00m2.60bn881.0026.252.35--6.140.47970.47972.055.350.33512.115.56748,197.707.71--8.68--50.81--23.00--15.96--0.0089--80.65--228.34------
Jiangsu Bioperfectus Technologies Co Ltd257.05m-201.87m2.60bn684.00--1.18--10.13-5.36-5.366.8358.770.09150.85921.57585,153.50-7.1925.41-8.3631.2663.2063.37-78.5332.866.05--0.08630.54-92.7211.81-120.45--2.43--
Japan Lifeline Co., Ltd.1.53bn224.40m2.63bn1.22k11.791.509.801.7198.5598.55675.02775.420.69371.443.8842,256,580.0010.158.6312.5710.8860.3057.2814.6312.281.96--0.073948.80-0.70732.459.06-0.54465.407.69
Qingdao NovelBeam Technology Co Ltd282.46m87.15m2.66bn797.0030.703.14--9.431.121.123.6210.950.31381.084.50551,832.809.4514.6710.0716.6362.5462.3230.1134.1511.88--0.003933.55-1.3118.58-20.1921.7110.45--
Shanghai Sanyou Medical Co Ltd247.89m37.79m2.67bn466.0073.322.17--10.760.2280.2281.537.710.16990.58912.20828,288.803.299.423.8610.8571.5287.1519.3429.783.35--0.029116.21-29.0815.67-49.918.99-15.60--
Data as of Jul 18 2024. Currency figures normalised to Supermax Corporation Bhd's reporting currency: Malaysian Ringgit MYR

Institutional shareholders

6.22%Per cent of shares held by top holders
HolderShares% Held
Hong Leong Asset Management Bhd.as of 29 Sep 202375.80m2.79%
The Vanguard Group, Inc.as of 29 Sep 202345.08m1.66%
BlackRock Fund Advisorsas of 03 Jul 202419.16m0.70%
Dimensional Fund Advisors LPas of 30 Apr 20246.66m0.25%
BlackRock Advisors (UK) Ltd.as of 04 Jul 20245.79m0.21%
Bank Julius Baer & Co. Ltd. (Singapore)as of 29 Sep 20234.31m0.16%
SSgA Funds Management, Inc.as of 03 Jul 20244.22m0.16%
American Century Investment Management, Inc.as of 03 Jul 20243.54m0.13%
Areca Capital Sdn. Bhd.as of 31 Mar 20242.85m0.11%
Research Affiliates LLCas of 31 Mar 20241.66m0.06%
More ▼
Data from 31 Jan 2024 - 31 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.